MeSH term
Frequency | Condition_Probility | Animals | 57 | 0.0 |
Female | 9 | 0.0 |
Humans | 78 | 0.0 |
Mice | 26 | 0.0 |
Mice, Inbred BALB C | 5 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Receptors, Polymeric Immunoglobulin/genetics | 2 | 100.0 |
Amino Acid Sequence | 21 | 0.0 |
Base Sequence | 19 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Cloning, Molecular | 9 | 0.0 |
Membrane Proteins/genetics/metabolism | 2 | 1.0 |
Molecular Sequence Data | 30 | 0.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Transfection | 14 | 0.0 |
Blotting, Western | 4 | 0.0 |
Cell Culture Techniques | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Epithelial Cells/metabolism | 4 | 1.0 |
Genes, Reporter | 3 | 0.0 |
Ligands | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 65 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 40 | 0.0 |
Cell Line | 26 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Organ Specificity | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Rats | 13 | 0.0 |
Receptors, Polymeric Immunoglobulin/*genetics | 6 | 100.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Species Specificity | 7 | 0.0 |
Comparative Study | 11 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Dogs | 14 | 1.0 |
Rabbits | 7 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Amino Acid Motifs | 4 | 0.0 |
Bacterial Adhesion/physiology | 2 | 14.0 |
Receptors, Polymeric Immunoglobulin/*physiology | 3 | 100.0 |
Time Factors | 3 | 0.0 |
*Bacterial Proteins | 2 | 1.0 |
DNA-Binding Proteins/genetics/immunology/metabolism | 2 | 40.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Streptococcus pneumoniae/*metabolism | 3 | 50.0 |
Binding Sites | 8 | 0.0 |
Biopolymers | 2 | 1.0 |
Dimerization | 10 | 0.0 |
Models, Molecular | 3 | 0.0 |
Mutation | 4 | 0.0 |
Protein Conformation | 3 | 0.0 |
Receptors, Polymeric Immunoglobulin/immunology | 2 | 100.0 |
Sequence Alignment | 7 | 0.0 |
Cell Polarity | 3 | 2.0 |
*Endocytosis | 2 | 1.0 |
Immunoglobulin A/metabolism | 6 | 11.0 |
Immunohistochemistry | 2 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Receptors, Polymeric Immunoglobulin/*metabolism | 6 | 75.0 |
Cycloheximide/pharmacology | 3 | 0.0 |
HT29 Cells | 6 | 3.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Protein Binding | 7 | 0.0 |
Receptors, Polymeric Immunoglobulin/biosynthesis/*genetics | 2 | 100.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Immunoglobulin A/immunology/*metabolism | 2 | 66.0 |
Immunoglobulin A, Secretory/metabolism | 3 | 23.0 |
Iodine Radioisotopes | 2 | 0.0 |
Bacterial Adhesion | 2 | 3.0 |
Biological Transport/physiology | 2 | 1.0 |
Cytokines/pharmacology | 2 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Receptors, Polymeric Immunoglobulin/genetics/*metabolism | 4 | 100.0 |
Gene Expression Regulation | 5 | 0.0 |
Gene Frequency | 3 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Epithelium/immunology | 3 | 2.0 |
Immunity, Mucosal | 5 | 7.0 |
COS Cells | 2 | 0.0 |
Caco-2 Cells | 4 | 1.0 |
Epitopes | 2 | 0.0 |
Immunoglobulin A, Secretory/chemistry/*metabolism | 2 | 66.0 |
Restriction Mapping | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Models, Genetic | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Receptors, Immunologic/*genetics | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Biological Transport | 6 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Epithelial Cells/*metabolism | 2 | 1.0 |
Kinetics | 4 | 0.0 |
Base Sequence/genetics | 2 | 0.0 |
DNA Footprinting | 2 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
In Vitro | 3 | 0.0 |
Polymers | 2 | 1.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Gene Expression | 5 | 0.0 |
Hamsters | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/immunology | 2 | 4.0 |
Drug Synergism | 2 | 0.0 |
RNA, Messenger/genetics | 3 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Kidney | 2 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Bile/immunology | 2 | 33.0 |
Male | 9 | 0.0 |
Secretory Component/metabolism | 5 | 55.0 |
Electrophoresis | 2 | 0.0 |
Secretory Component/*metabolism | 2 | 15.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Rats/genetics | 2 | 7.0 |
*Cell Polarity | 2 | 5.0 |
Epithelial Cells/*immunology | 2 | 10.0 |
Colonic Neoplasms | 2 | 1.0 |
Interferon Type II/*pharmacology | 4 | 0.0 |
Interleukin-4/*pharmacology | 2 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Immunoglobulin A/*metabolism | 4 | 13.0 |
Cell Membrane/metabolism | 4 | 0.0 |
Immunoglobulin A/*immunology | 3 | 11.0 |
Biological Transport/immunology | 2 | 7.0 |
Epithelial Cells | 3 | 0.0 |
Molecular Weight | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Cattle | 3 | 0.0 |
Adult | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Secretory Component/*biosynthesis/genetics | 2 | 66.0 |
Open Reading Frames | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cell Polarity/*physiology | 2 | 8.0 |
Epithelium/*metabolism | 2 | 8.0 |
Secretory Component/*genetics | 3 | 60.0 |
Receptors, Immunologic | 5 | 13.0 |
Exocytosis/*physiology | 2 | 6.0 |
DNA Primers | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Case-Control Studies | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Mucous Membrane/immunology | 2 | 7.0 |
